First Mercantile Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $78K | Sell |
443
-21
| -5% | -$3.7K | 0.01% | 719 |
|
|
2021
Q2 | $75K | Sell |
464
-247
| -35% | -$39.9K | 0.01% | 750 |
|
|
2021
Q1 | $122K | Sell |
711
-317
| -31% | -$54.4K | 0.01% | 618 |
|
|
2020
Q4 | $226K | Sell |
1,028
-93
| -8% | -$20.4K | 0.03% | 377 |
|
|
2020
Q3 | $255K | Sell |
1,121
-381
| -25% | -$86.7K | 0.03% | 317 |
|
|
2020
Q2 | $171K | Buy |
1,502
+297
| +25% | +$33.8K | 0.02% | 465 |
|
|
2020
Q1 | $93K | Buy |
1,205
+187
| +18% | +$14.4K | 0.01% | 578 |
|
|
2019
Q4 | $131K | Sell |
1,018
-151
| -13% | -$19.4K | 0.02% | 598 |
|
|
2019
Q3 | $91K | Buy |
1,169
+301
| +35% | +$23.4K | 0.01% | 717 |
|
|
2019
Q2 | $89K | Buy |
+868
| New | +$89K | 0.01% | 675 |
|
|
2015
Q4 | – | Sell |
-4,469
| Closed | -$154K | – | 986 |
|
|
2015
Q3 | $154K | Buy |
+4,469
| New | +$154K | 0.02% | 711 |
|